11.80
Schlusskurs vom Vortag:
$11.75
Offen:
$11.85
24-Stunden-Volumen:
26,916
Relative Volume:
0.25
Marktkapitalisierung:
$309.76M
Einnahmen:
$59,000
Nettoeinkommen (Verlust:
$-21.81M
KGV:
-1.0774
EPS:
-10.9518
Netto-Cashflow:
$-18.07M
1W Leistung:
+7.66%
1M Leistung:
-6.50%
6M Leistung:
+12.27%
1J Leistung:
+36.26%
Benitec Biopharma Inc Stock (BNTC) Company Profile
Firmenname
Benitec Biopharma Inc
Sektor
Branche
Telefon
(510) 780-0819
Adresse
3940 TRUST WAY, HAYWARD, CA
Vergleichen Sie BNTC mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BNTC
Benitec Biopharma Inc
|
11.80 | 305.82M | 59,000 | -21.81M | -18.07M | -10.95 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
![]()
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Benitec Biopharma Inc Stock (BNTC) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-07-07 | Eingeleitet | TD Cowen | Buy |
2024-12-16 | Eingeleitet | H.C. Wainwright | Buy |
2024-12-13 | Eingeleitet | Robert W. Baird | Outperform |
2024-10-16 | Eingeleitet | Oppenheimer | Outperform |
2024-09-12 | Eingeleitet | Guggenheim | Buy |
2024-07-22 | Eingeleitet | Leerink Partners | Outperform |
2024-06-13 | Eingeleitet | Piper Sandler | Overweight |
2020-10-05 | Herabstufung | Ladenburg Thalmann | Buy → Neutral |
2020-04-20 | Eingeleitet | Ladenburg Thalmann | Buy |
2016-02-26 | Herabstufung | Maxim Group | Buy → Hold |
2015-12-31 | Bestätigt | Maxim Group | Buy |
2015-09-16 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Benitec Biopharma Inc Aktie (BNTC) Neueste Nachrichten
Tools to assess Benitec Biopharma Inc.’s risk profileEntry Zone Watchlist With Momentum Focus - Newser
What data driven models say about Benitec Biopharma Inc.’s futureNeural Model for Stock Price Movement - Newser
Should you hold or exit Benitec Biopharma Inc. nowMarket Sentiment Tracker with Smart Alerts - Newser
Will Benitec Biopharma Inc. continue its uptrendDownside Risk Evaluation and Stock Analysis - Newser
How Benitec Biopharma Inc. stock performs during market volatilityIntraday Movement Recap and Chart Summary - Newser
Why Benitec Biopharma Inc. is moving todayWeekly Breakout Forecast with Entry Zones - Newser
What to do if you’re stuck in Benitec Biopharma Inc.Entry Optimization Guide with Volume Analysis - Newser
Real time scanner hits for Benitec Biopharma Inc. explainedHigh Reward Investment Strategy for Beginners - Newser
Does Benitec Biopharma Inc. stock pay reliable dividendsWeekly Movement Forecast With Chart Signals - Newser
What makes Benitec Biopharma Inc. stock price move sharplyFree AI-Powered Trade Planning with Indicators - Newser
Does Benitec Biopharma Inc. fit your quant trading modelAI Pattern Recognition and Trade Prediction - Newser
News impact scoring models applied to Benitec Biopharma Inc.Free Short Term Trading Opportunity Watch - Newser
Will Benitec Biopharma Inc. Stock Benefit from AI and Green Energy TrendsLong-Term Trend Tracking and Signal Summary - Newser
Why Benitec Biopharma Inc. stock attracts strong analyst attentionSummary of Long-Term Buy Zone Stocks - Newser
Predicting Benitec Biopharma Inc. trend using moving averagesFree Daily Chart Pattern Stock Forecast - Newser
Benitec Biopharma Sees Bullish Signal with KDJ Golden Cross and Bullish Marubozu Pattern. - AInvest
Will a bounce in Benitec Biopharma Inc. offer an exitFree Low Risk Equity Screener With Results - Newser
Can you recover from losses in Benitec Biopharma Inc.Trade Safety Matrix for Conservative Traders - Newser
How strong is Benitec Biopharma Inc. company’s balance sheetIdentify winners with top-tier analysis - Jammu Links News
What catalysts could drive Benitec Biopharma Inc. stock higher in 2025Triple-digit returns - Jammu Links News
Is Benitec Biopharma Inc. a growth stock or a value stockBreakout profit opportunities - Jammu Links News
How does Benitec Biopharma Inc. generate profit in a changing economySuperior portfolio returns - Jammu Links News
What are the technical indicators suggesting about Benitec Biopharma Inc.Maximize profits with strategic stock selection - Jammu Links News
Is it the right time to buy Benitec Biopharma Inc. stockGet timely market insights for better trades - Jammu Links News
Should I hold or sell Benitec Biopharma Inc. stock in 2025Significant capital appreciation - Jammu Links News
Finanzdaten der Benitec Biopharma Inc-Aktie (BNTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Benitec Biopharma Inc-Aktie (BNTC) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Mar 26 '25 |
Buy |
13.00 |
900,000 |
11,700,000 |
8,793,245 |
BUCHI J KEVIN | Director |
Feb 27 '25 |
Option Exercise |
3.86 |
51,813 |
199,998 |
103,910 |
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 23 '24 |
Buy |
10.98 |
27,502 |
301,972 |
7,981,725 |
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 24 '24 |
Buy |
11.25 |
20,018 |
225,202 |
7,999,455 |
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Dec 03 '24 |
Buy |
9.60 |
42,000 |
403,200 |
7,957,365 |
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 20 '24 |
Buy |
10.22 |
27,436 |
280,396 |
7,920,175 |
SUVRETTA CAPITAL MANAGEMENT, L | Director |
Nov 19 '24 |
Buy |
9.73 |
14,000 |
136,220 |
7,895,815 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):